BioPassport

BIOT

A telehealth platform

39%
Transparency Score

$0.0004196

3.57%
  • Trading Volume(24h)
    -94.86% $561,201.57
  • Circulating Market Cap
    $3,634,406.47 #1344
  • FDV
    $3,693,183.34
  • Circulating Supply
    8,659,948,355.999 BIOT
  • Total Supply
    8,800,000,000 BIOT
  • All-time High
    $0.1468 (Dec 20, 2021)
  • All-time Low
    $0.0007803 (Jun 15, 2023)
  • Contract Address
  • Supported Exchanges
    Bithumb
Analytics
Analytics
Collapse
Performances
Comparison
Essentials
Essentials
Collapse
Details
Financials
Financials
Collapse
Top Holders
Trade
Trade
Collapse
Open Markets
𝕏 Data
𝕏 Data
Collapse
Follow Lists

Performances

RD Popularity Index

39
5.41% (24h)
0 100 200 300 400
Project Rank: 3791/19141

RD Growth Index

19
0% (24h)
0 500 1000 1500 2000
Project Rank: 8185/19141
1h 24h 7d 30d 60d 90d
0.08% 3.57% 7.29% 3.02% 39.22% 52.44%

Comparison

Total Raised: --
Fundraising not disclosed
FDV: --
Token not listed
24h Trading Volume: --
Token not listed
Project Name
Intro
--
Total Raised
--
Core Team
--
Core Investors
--
RD Growth Index (7d %)
--
RD Popularity Index (7d %)
--

Details

Bio Passport is a telehealth platform that can remotely monitor personal health in the post-COVID-19 era. It supports management of personal healthcare data based on distributed identity technology, and provides COVID-19, lung cancer and atopic test kits, as well as a token compensation system.

Top Holders

Open Markets

--
#
Exchange
Pair
Price
+2% depth
-2% depth
Volume (24h)
volume %
No Data

𝕏 Follow Lists

$0.0004196

3.57%
  • Trading Volume(24h)
    -94.86% $561,201.57
  • Circulating Market Cap
    $3,634,406.47 #1344
  • FDV
    $3,693,183.34
  • Circulating Supply
    8,659,948,355.999 BIOT
  • Total Supply
    8,800,000,000 BIOT
  • All-time High
    $0.1468 (Dec 20, 2021)
  • All-time Low
    $0.0007803 (Jun 15, 2023)
  • Contract Address
  • Supported Exchanges
    Bithumb
Rate BioPassport
0.0
Rated by 0 users
What’s your take on BioPassport? Share your review.
Reviews and ratings are posted by users, do not constitute financial advice, and do not represent the views of the platform.